×

Immunonanotherapeutics Providing a Th1-Biased Response

  • US 20110223201A1
  • Filed: 04/21/2010
  • Published: 09/15/2011
  • Est. Priority Date: 04/21/2009
  • Status: Abandoned Application
First Claim
Patent Images

1. A composition for treatment of a condition comprising:

  • synthetic nanocarriers comprising (1) an immunofeature surface, and (2) a Th1 biasing immunostimulatory agent coupled to the synthetic nanocarriers; and

    a pharmaceutically acceptable excipient;

    wherein the immunofeature surface does not comprise antigen that is relevant to treatment of the condition in an amount sufficient to provoke an adaptive immune response to the antigen that is relevant to treatment of the condition.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×